AbbVie Inc. (ABBV) Earnings History
Annual and quarterly earnings data from 2010 to 2025
Loading earnings history...
ABBV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ABBV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 70.2% | 32.8% | 6.9% |
| 2024 | 70.0% | 16.2% | 7.6% |
| 2023 | 62.4% | 23.5% | 9.0% |
| 2022 | 70.0% | 31.2% | 20.4% |
| 2021 | 69.0% | 31.9% | 20.5% |
Download Data
Export ABBV earnings history in CSV or JSON format
Free sign-in required to download data
AbbVie Inc. (ABBV) Earnings Overview
As of May 6, 2026, AbbVie Inc. (ABBV) reported trailing twelve-month net income of $4.23B, reflecting -0.8% year-over-year growth. The company earned $2.38 per diluted share over the past four quarters, with a net profit margin of 6.9%.
Looking at the long-term picture, ABBV's 5-year EPS compound annual growth rate (CAGR) stands at -2.7%, signaling declining earnings. The company achieved its highest annual net income of $11.84B in fiscal 2022.
AbbVie Inc. maintains positive profitability with a gross margin of 70.2%, operating margin of 32.8%, and net margin of 6.9%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including JNJ ($25.12B net income, 15.8% margin), MRK ($18.25B net income, 28.1% margin), PFE ($7.49B net income, 12.4% margin), ABBV has room to improve margins relative to the peer group. Compare ABBV vs JNJ →
ABBV Earnings vs Peers
Earnings metrics vs comparable public companies
ABBV Historical Earnings Data (2010–2025)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.23B | -1.2% | $20.09B | $2.37 | 6.9% | 32.8% |
| 2024 | $4.28B | -12.0% | $9.14B | $2.39 | 7.6% | 16.2% |
| 2023 | $4.86B | -58.9% | $12.76B | $2.72 | 9.0% | 23.5% |
| 2022 | $11.84B | +2.5% | $18.12B | $6.63 | 20.4% | 31.2% |
| 2021 | $11.54B | +150.0% | $17.92B | $6.45 | 20.5% | 31.9% |
| 2020 | $4.62B | -41.4% | $11.36B | $2.72 | 10.1% | 24.8% |
| 2019 | $7.88B | +38.6% | $12.98B | $5.28 | 23.7% | 39.0% |
| 2018 | $5.69B | +7.1% | $6.38B | $3.68 | 17.4% | 19.5% |
| 2017 | $5.31B | -10.8% | $9.54B | $3.30 | 18.8% | 33.8% |
| 2016 | $5.95B | +15.7% | $9.34B | $3.63 | 23.2% | 36.4% |
Full ABBV Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy ABBV Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See ABBV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABBV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABBV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABBV — Frequently Asked Questions
Quick answers to the most common questions about buying ABBV stock.
Is ABBV growing earnings?
ABBV EPS of $2.38 reflects slowing growth at -0.8%, below the 5-year CAGR of -2.7%. TTM net income is $4.2B. Expansion rate has moderated.
What are ABBV's profit margins?
AbbVie Inc. net margin is +6.9%, with operating margin at +32.8%. Margins sit within typical range for the sector.
How consistent are ABBV's earnings?
ABBV earnings data spans 2010-2025. The current earnings trend is -0.8% YoY. Historical data enables comparison across business cycles.